ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tommy R. Reynolds
Willard M. Daggett
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, T. R.
Right arrow Articles by Daggett, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T. R.
Right arrow Articles by Daggett, W. M.

Ann Thorac Surg 1989;47:907-913
© 1989 The Society of Thoracic Surgeons


Articles

Myocardial preservation related to magnesium content of hyperkalemic cardioplegic solutions at 8 °C

Tommy R. Reynolds, MD, Gillian A. Geffin, MB, BS, James S. Titus, Dennis D. O'Keefe, MD, Willard M. Daggett, MD*

Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts USA

Accepted for publication January 25, 1989.

* Address reprint requests to Dr Daggett, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114.

This study investigates whether the addition of magnesium to a hyperkalemic cardioplegic solution containing 0.1 mM ionized calcium improves myocardial preservation, and whether there is an optimal magnesium concentration in this solution. Isolated perfused rat hearts were arrested for two hours by this cardioplegic solution, which was fully oxygenated and infused at 8 °C every 15 minutes to simulate clinical conditions. The cardioplegic solution contained either 0, 2, 4, 8, 16, or 32 mM magnesium. At end-arrest, the myocardial creatine phosphate concentration (nanomoles per milligram of dry weight) was 20.7 ± 2.1, 22.9 ± 1.7, 24.8 ± 2.0, 31.3 ± 1.4, 33.1 ± 1.8, and 31.6 ± 0.8, respectively, in hearts given cardioplegic solution containing these magnesium concentrations. Thus, the concentration of creatine phosphate was significantly higher at end-arrest when the cardioplegic solution contained 8, 16, or 32 mM than 0 or 2 mM magnesium (p < 0.002) or 4 mM magnesium (p < 0.02), and highest with 16 mM magnesium. Also, creatine phosphate was more sensitive to the magnesium concentration of the cardioplegic solution than was end-arrest adenosine triphosphate levels, which did not differ among the experimental groups. Aortic flow, expressed as a percentage of prearrest aortic flow, was 60.3 ± 5.0, 70.2 ± 5.5, 71.6 ± 4.4, 71.8 ± 4.8, 81.0 ± 5.0, and 71.8 ±5.3, respectively. The addition of magnesium to the cardioplegic solution improved recovery of aortic flow (p < 0.05, 16 mM versus 0 mM magnesium). We conclude from these data that with deep myocardial hypothermia and at an ionized calcium concentration of 0.1 mM, the addition of magnesium, over a broad concentration range, improved preservation of myocardial creatine phosphate and, at a concentration of 16 mM, improved aortic flow. The optimal magnesium concentration in the cardioplegic solution was 16 mM.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. R. Lopez, R. Jahangir, A. Jahangir, W. K. Shen, and A. Terzic
POTASSIUM CHANNEL OPENERS PREVENT POTASSIUM-INDUCED CALCIUM LOADING OF CARDIAC CELLS: POSSIBLE IMPLICATIONS IN CARDIOPLEGIA
J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 820 - 831.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. Caspi, E. Rudis, I. Bar, T. Safadi, and M. Saute
Effects of magnesium on myocardial function after coronary artery bypass grafting
Ann. Thorac. Surg., April 1, 1995; 59(4): 942 - 947.
[Abstract] [PDF]


Home page
JAMAHome page
M. R. England, G. Gordon, M. Salem, and B. Chernow
Magnesium Administration and Dysrhythmias After Cardiac Surgery: A Placebo-Controlled, Double-blind, Randomized Trial
JAMA, November 4, 1992; 268(17): 2395 - 2402.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. A. Geffin, T. R. Reynolds, J. S. Titus, D. D. O'Keefe, and W. M. Daggett
Relation of myocardial protection to cardioplegic solution pH: Modulation by calcium and magnesium
Ann. Thorac. Surg., October 1, 1991; 52(4): 955 - 964.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. S. Brown Jr, F. W. Holland, G. L. Parenteau, and R. E. Clark
Magnesium ion is beneficial in hypothermic crystalloid cardioplegia
Ann. Thorac. Surg., March 1, 1991; 51(3): 359 - 367.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The Society of Thoracic Surgeons.